Fetal akinesia-cerebral and retinal hemorrhage syndrome is a very rare genetic condition that usually begins before birth. Early signs of fetal akinesia-cerebral and retinal hemorrhage syndrome can include reduced fetal movement, stiff joints, and serious bleeding in the brain and eyes. It is most often recognized during pregnancy or at birth, and the condition is lifelong in babies who survive. Not everyone will have the same experience, but this syndrome is often severe and can lead to stillbirth or death in early infancy. There is no cure, so treatment focuses on supportive care for breathing, feeding, seizures, and other complications.
How many people live with Fetal akinesia-cerebral and retinal hemorrhage syndrome?
There are no reliable published estimates for how many people are living with fetal akinesia-cerebral and retinal hemorrhage syndrome worldwide or in the United States. It appears to be exceptionally rare and has only been described in a very small number of families in the medical literature, so experts do not have a dependable global or U.S. count.
Overview
Fetal akinesia-cerebral and retinal hemorrhage syndromeSymptoms
Fetal akinesia-cerebral and retinal hemorrhage syndrome causes very little movement before birth, severe weakness, and joint stiffness or contractures. Common features also include brain bleeding and bleeding in the eyes, which may be seen on scans or after delivery.
Outlook and prognosis
Fetal akinesia-cerebral and retinal hemorrhage syndrome is usually very severe and often life-limiting before or shortly after birth. For families affected by fetal akinesia-cerebral and retinal hemorrhage syndrome, care centers on comfort, support, and clear guidance about future pregnancy risks.
Causes and risk factors
Fetal akinesia-cerebral and retinal hemorrhage syndrome is a rare genetic condition caused by harmful changes in a gene, often passed down from both parents who are unaffected carriers. Lifestyle or environmental factors are not known primary causes.
Genetic influences
Genetics are central to fetal akinesia-cerebral and retinal hemorrhage syndrome. It is linked to harmful gene changes, often inherited from both parents, so genetic testing can help confirm the diagnosis and clarify recurrence risk for future pregnancies.
Diagnosis
Doctors diagnose fetal akinesia-cerebral and retinal hemorrhage syndrome by combining clinical features with imaging findings. Prenatal ultrasound or MRI may show reduced movement and brain changes. Genetic testing can confirm the diagnosis of fetal akinesia-cerebral and retinal hemorrhage syndrome.
Treatment and drugs
Care for fetal akinesia-cerebral and retinal hemorrhage syndrome focuses on comfort, breathing, and feeding support. Specialists may monitor the brain and eyes and treat complications such as seizures. Genetic counseling can help families understand future pregnancy risks.
Symptoms
This syndrome is usually first noticed before birth, when a baby moves much less than expected and ultrasound findings raise concern. Early on, this might look like fewer kicks during pregnancy, stiff joints at birth, or serious problems affecting the brain and eyes. In fetal akinesia-cerebral and retinal hemorrhage syndrome, the signs are present before or at birth, although the exact combination can vary.
One of the earliest signs is reduced movement during pregnancy, so the pregnant parent may feel fewer kicks than expected. Reduced movement is one of the early features of fetal akinesia-cerebral and retinal hemorrhage syndrome and can also affect joint, lung, and overall body development.
Limited movement before birth often leads to joints that are bent or fixed in place at birth, especially in the arms and legs. These contractures can make positioning, routine care, and later movement more difficult.
Bleeding in the brain can happen before birth or around the time of birth and may cause serious injury. In fetal akinesia-cerebral and retinal hemorrhage syndrome, this can lead to seizures, unusual muscle tone, or major developmental challenges.
Bleeding in the retina, the light-sensing tissue at the back of the eye, can affect vision very early in life. Some babies have poor visual responses, and some have severe sight loss.
How people usually first notice Fetal akinesia-cerebral and retinal hemorrhage syndrome?
Fetal akinesia-cerebral and retinal hemorrhage syndrome is usually first noticed before birth, when doctors or parents become concerned that the baby is moving much less than expected on ultrasound, sometimes along with fixed limb positions or joint contractures. After birth, the first signs of fetal akinesia-cerebral and retinal hemorrhage syndrome often include severe weakness, trouble breathing or feeding, and findings on eye or brain exams that show retinal or cerebral bleeding. Because this condition is rare and severe, it is most often recognized early through a combination of reduced fetal movement, newborn symptoms, and specialist testing soon after delivery.
Types of Fetal akinesia-cerebral and retinal hemorrhage syndrome
No distinct types of Fetal akinesia-cerebral and retinal hemorrhage syndrome are widely recognized.
Can I slow down the onset of symptoms?
No. There is currently no good evidence that lifestyle changes or medical treatment can meaningfully delay the start of symptoms in fetal akinesia-cerebral and retinal hemorrhage syndrome, because it is a very rare inherited condition that begins before birth. There is also no proven way to prevent it once a pregnancy is affected, although families with a known history may benefit from gene testing and counseling to better understand the chance in a future pregnancy; research is ongoing, but for now the most helpful step is early specialist support and honest planning.
What genetics can tell you about symptoms
In fetal akinesia-cerebral and retinal hemorrhage syndrome, the genetic change is mainly helpful for confirming the diagnosis rather than predicting exactly how symptoms will look in one baby. People with changes in the same gene can still have some differences in how early problems begin and how severe they are, but the condition usually starts before birth and is marked by very reduced movement along with serious bleeding in the brain and eyes. In other words, genetics can strongly point to the syndrome itself, but it cannot yet reliably forecast the full symptom pattern or outcome for every pregnancy.
Causes and risk factors
Most reported cases of fetal akinesia-cerebral and retinal hemorrhage syndrome are linked to harmful changes in the JAM3 gene. The condition is usually inherited from both parents, so risk is highest when both parents are carriers. A family history of the syndrome or parents who are blood relatives can raise the chance of carrying the same rare gene change. Lifestyle, diet, and common pregnancy exposures are not known to be the main cause of fetal akinesia-cerebral and retinal hemorrhage syndrome. Genetic testing can sometimes clarify your personal risk.
What are the most common causes or risk factors?
This very rare condition is most often caused by an inherited gene change, most commonly in a gene called JAM3, and it usually happens when a baby receives a nonworking copy of the gene from both parents. The main known risk factors are having a family history of the condition, having had a previously affected pregnancy, or the parents being blood relatives, which raises the chance that both carry the same rare gene change. No common lifestyle, diet, or environmental cause has been clearly proven.
Environmental and biological risk factors
Fetal akinesia-cerebral and retinal hemorrhage syndrome is a very rare condition present before birth, and environmental risk factors for fetal akinesia-cerebral and retinal hemorrhage syndrome are not well defined. Researchers are still exploring how outside influences interact with our inner biology. Right now, no well-established environmental exposures or non-genetic biological factors have been clearly shown to increase the chance of this syndrome.
No specific infection, toxin, medication, or other pregnancy exposure has been proven to raise the chance of this syndrome. Because so few cases have been reported, firm environmental risk factors have not been confirmed.
Common biological factors such as maternal age or routine pregnancy health problems have not been clearly linked to fetal akinesia-cerebral and retinal hemorrhage syndrome. If prenatal imaging raises concern, a fetal medicine specialist can explain what is known and where the evidence is still limited.
Genetic risk factors
Most reported cases of fetal akinesia-cerebral and retinal hemorrhage syndrome are linked to harmful changes in a gene called JAM3, which helps the lining of developing blood vessels stay intact. Some risk factors are inherited through our genes. Because this condition is passed through families, understanding the genetic causes of fetal akinesia-cerebral and retinal hemorrhage syndrome can help with testing and future pregnancy planning. In many families, the main risk comes from both parents carrying one changed copy of the same gene without knowing it.
JAM3 changes: Most reported cases are caused by harmful changes in both copies of the JAM3 gene. When this gene is not working properly, fragile blood vessels in the developing brain and eyes can bleed before birth.
Recessive inheritance: Fetal akinesia-cerebral and retinal hemorrhage syndrome is usually inherited in an autosomal recessive pattern. This means a baby typically receives one nonworking copy of the gene from each parent.
Carrier parents: Parents who each carry one changed JAM3 gene usually do not have symptoms themselves. If two carriers have a pregnancy together, the chance of having an affected baby is 1 in 4, or 25%, in each pregnancy.
Family history: A family history of this syndrome, or of a previous pregnancy with similar findings such as very little fetal movement and bleeding in the brain or eyes, can raise the chance that the same inherited change is present. This can be an important clue even when the parents are healthy.
Shared ancestry: Parents who are biologically related, such as cousins, are more likely to carry the same rare gene change from a shared ancestor. This raises the risk of rare recessive conditions like fetal akinesia-cerebral and retinal hemorrhage syndrome.
Future pregnancies: After one affected pregnancy in a carrier couple, the recurrence risk usually stays the same for each future pregnancy. That means each pregnancy again has a 1 in 4, or 25%, chance of being affected.
Lifestyle risk factors
Fetal akinesia-cerebral and retinal hemorrhage syndrome is an inherited disorder, so lifestyle habits do not cause it. In practice, how lifestyle affects Fetal akinesia-cerebral and retinal hemorrhage syndrome is mainly through injury prevention, feeding support, and reducing complications related to limited movement, brain injury, and visual impairment. The most relevant lifestyle risk factors are those that increase bleeding, worsen contractures, raise infection risk, or make daily care less safe.
Unsafe transfers, poor seating support, or cluttered surroundings can increase the chance of trauma in a child already vulnerable to brain or retinal complications. Careful positioning, protective equipment when advised, and adapted home safety may reduce preventable injuries.
Too little guided movement can worsen stiffness, joint contractures, and discomfort in children with severe fetal akinesia. Regular stretching, positioning routines, and therapist-directed activity may help preserve comfort and function within the child’s limits.
Inadequate feeding routines or poor swallow safety can lead to undernutrition, dehydration, or aspiration in children with neurologic impairment. Texture modification, paced feeding, and close attention to swallowing plans can improve growth and reduce lung complications.
Immobility and weak airway clearance can make chest infections more likely, especially when daily routines do not include repositioning or secretion management. Good hydration, upright positioning when appropriate, and prescribed airway clearance practices can support breathing health.
Risk prevention
Fetal akinesia-cerebral and retinal hemorrhage syndrome is a rare genetic condition, so there is usually no way to prevent the syndrome itself after conception. In most families, prevention is mainly about understanding genetic risk before or during pregnancy, and lowering the chance of serious complications with close specialist care. Different people need different prevention strategies—there’s no single formula. For families worried about early symptoms of fetal akinesia-cerebral and retinal hemorrhage syndrome in a pregnancy, early monitoring can help guide care and planning.
Meeting with a genetics specialist before pregnancy can help clarify whether fetal akinesia-cerebral and retinal hemorrhage syndrome could happen again in your family. This may include reviewing family history and offering carrier or DNA testing when the gene change is known.
If a disease-causing gene change has already been identified in a family, some may choose options such as IVF with embryo testing or targeted testing during pregnancy. These steps cannot treat fetal akinesia-cerebral and retinal hemorrhage syndrome, but they may help lower the chance of an unexpected affected pregnancy or provide earlier answers.
In pregnancies at known risk, regular ultrasound and maternal-fetal medicine follow-up may help spot reduced fetal movement or related concerns sooner. Prevention works best when combined with regular check-ups, especially when decisions about delivery, supportive care, or further testing may be needed.
Close care from obstetrics, genetics, and newborn specialists can help reduce preventable complications linked to fetal akinesia-cerebral and retinal hemorrhage syndrome. While this does not prevent the genetic condition, it can improve planning for birth, breathing support, and urgent newborn care if needed.
Can you prevent Fetal akinesia-cerebral and retinal hemorrhage syndrome?
Fetal akinesia-cerebral and retinal hemorrhage syndrome usually cannot be prevented, because it is a very rare inherited condition caused by a change in a gene rather than something a parent did or did not do. If it has happened in your family, genetic counseling before pregnancy can help you understand the chance of it happening again and talk through testing or family-building options, but it cannot guarantee prevention.
Transmission
Fetal akinesia-cerebral and retinal hemorrhage syndrome is not infectious, so it does not spread from person to person through contact, the air, food, or body fluids.
Instead, the genetic transmission of Fetal akinesia-cerebral and retinal hemorrhage syndrome usually happens when a baby inherits two changed copies of the same gene, one from each parent. In most families, both parents are healthy carriers, meaning they each have one changed copy but do not have the syndrome themselves. When both parents are carriers, each pregnancy has a 1 in 4, or 25%, chance of the baby being affected.
When to test your genes
Consider genetic testing if a pregnancy shows markedly reduced fetal movement, joint contractures, or abnormal prenatal ultrasound findings, especially with a family history or a previously affected pregnancy. Testing can help confirm the diagnosis, clarify recurrence risk, and guide prenatal, newborn, and eye and neurologic care.
Diagnosis
Doctors usually diagnose fetal akinesia-cerebral and retinal hemorrhage syndrome by putting together findings seen before birth or at delivery with brain, eye, and genetic testing. Because this is a very rare inherited condition, the diagnosis often starts when reduced fetal movement, joint contractures, or bleeding in the brain or eyes raises concern. The genetic diagnosis of fetal akinesia-cerebral and retinal hemorrhage syndrome is used to confirm the cause and to help families understand recurrence risk.
Ultrasound may show very little fetal movement, fixed limb positions, extra fluid around the baby, or other signs that the baby is not moving normally. These prenatal findings can be the first clue that a serious neuromuscular or genetic condition is present.
After birth or after pregnancy loss, doctors look for contractures, also called joints that are stiff or fixed in one position, along with reduced muscle movement. The overall pattern of these clinical features helps point toward fetal akinesia-cerebral and retinal hemorrhage syndrome rather than a more common cause of decreased movement.
Doctors may perform brain imaging such as ultrasound or MRI to look for cerebral hemorrhage and related injury. An eye exam can show retinal hemorrhages, which are an important part of the diagnosis of fetal akinesia-cerebral and retinal hemorrhage syndrome.
Your provider may suggest genetic tests to look for a disease-causing change in a gene linked to this syndrome. Finding the underlying variant confirms the diagnosis and can help guide testing for parents and future pregnancies.
How is Fetal akinesia-cerebral and retinal hemorrhage syndrome diagnosed?
Doctors usually suspect fetal akinesia-cerebral and retinal hemorrhage syndrome during pregnancy or soon after birth when a baby shows very little movement and scans show bleeding in the brain and eyes, often along with stiff or fixed joints. The diagnosis is based on this pattern of findings using prenatal ultrasound, sometimes a more detailed scan called MRI, and an eye exam after birth, while also checking for other possible causes of poor movement or bleeding. Genetic testing may also be offered to help confirm an inherited cause, especially if there is a family history or the diagnosis is unclear.
Stages of Fetal akinesia-cerebral and retinal hemorrhage syndrome
Fetal akinesia-cerebral and retinal hemorrhage syndrome does not have defined progression stages. This is because it is a rare developmental condition that is identified by a pattern of findings, often before birth or around the time of delivery, rather than by a gradual step-by-step worsening over time. Early symptoms of fetal akinesia-cerebral and retinal hemorrhage syndrome are usually picked up through prenatal ultrasound, reduced fetal movement, and then brain and eye findings seen on imaging or specialist examination after birth. Identifying the cause is the starting point for the right care, and doctors may also use genetic testing and careful review of pregnancy and family history to confirm the diagnosis and guide counseling.
Outlook and prognosis
The outlook for fetal akinesia-cerebral and retinal hemorrhage syndrome is generally poor, based on the small number of reported cases. Many affected pregnancies end in stillbirth, neonatal death, or death in early infancy because of severe prenatal brain injury and the complications of markedly reduced fetal movement. In the uncommon children who survive beyond the newborn period, prognosis is typically guarded, with profound neurodevelopmental impairment, severe motor disability, feeding and breathing difficulties, and major visual impairment. Seizures and other neurologic complications can further worsen long-term outcome. Because the condition is extremely rare, exact survival rates are not available, but overall mortality appears to be high.
Long-term effects
For many families, the long-term picture of fetal akinesia-cerebral and retinal hemorrhage syndrome is very serious from the start. This condition is often linked to major brain, eye, and movement-related problems, and in many cases it is life-limiting before birth or in early infancy. In children who survive, long-term effects vary widely but usually involve severe developmental and physical disabilities.
Fetal akinesia-cerebral and retinal hemorrhage syndrome is often associated with a high risk of stillbirth or death in the newborn period. When survival is possible, the outlook depends on how severe the brain bleeding, reduced movement before birth, and other organ problems were.
Children who survive often have profound delays in learning, communication, and everyday skills. Many living with fetal akinesia-cerebral and retinal hemorrhage syndrome do not reach expected milestones such as sitting, walking, or speaking in the usual time frame.
Reduced movement before birth can lead to lasting muscle weakness, stiff joints, and limited mobility. Some may have contractures, meaning joints are fixed in a bent or straight position, which can affect posture and physical development over time.
Bleeding in the brain can leave permanent damage that affects thinking, movement, and body control. Some effects may be seizures, poor muscle tone or increased stiffness, while others can be problems with swallowing or breathing coordination.
How is it to live with Fetal akinesia-cerebral and retinal hemorrhage syndrome?
For many families, life with fetal akinesia-cerebral and retinal hemorrhage syndrome begins with a pregnancy marked by very little fetal movement and then devastating news on scans or after birth. This is a very severe genetic condition, and many affected babies do not survive pregnancy or die shortly after birth; when a baby is born alive, care is usually centered on intensive medical support and comfort because the brain and eye bleeding can cause profound injury. The impact reaches far beyond the baby, often bringing repeated hospital visits, difficult decisions, and deep emotional strain for parents, siblings, and other loved ones, so counseling, palliative care, and genetic support can be especially important.
Treatment and drugs
Fetal akinesia-cerebral and retinal hemorrhage syndrome has no cure, so treatment focuses on supportive care before and after birth and depends on how severely the baby is affected. During pregnancy, care usually centers on close monitoring, planning delivery in a hospital with high-risk pregnancy and newborn specialists, and talking through what treatment may or may not help after birth. After delivery, doctors may use intensive support such as help with breathing, feeding, and seizures if these problems occur, but many babies with fetal akinesia-cerebral and retinal hemorrhage syndrome are very sick and may need comfort-focused care instead of invasive treatment. It’s natural to have questions about treatment, and families are often offered genetic counseling as well, since this condition is inherited and future pregnancy planning may be part of care.
Can you cure Fetal akinesia-cerebral and retinal hemorrhage syndrome?
No, there is currently no cure for fetal akinesia-cerebral and retinal hemorrhage syndrome. Treatment cannot reverse the condition, but care may help with breathing, feeding, comfort, and other serious problems, and families are often offered supportive care and guidance about future pregnancies.
Non-drug treatment
For families affected by fetal akinesia-cerebral and retinal hemorrhage syndrome, care is usually centered on comfort, safety, and day-to-day support rather than a disease-specific treatment. Many living with this condition have severe movement problems from before birth, along with brain and eye injury, so non-drug care often involves several specialists working together. Supportive therapies can help with breathing, feeding, positioning, and family decision-making, although needs vary widely and some babies are very medically fragile. In practice, the best plan depends on how severe the early symptoms of fetal akinesia-cerebral and retinal hemorrhage syndrome are and whether the baby survives the newborn period.
Breathing support may include oxygen, suctioning, careful airway positioning, and, when needed, noninvasive or mechanical ventilation. Chest physical therapy and close monitoring can help reduce mucus build-up and breathing distress.
Many babies cannot feed safely by mouth because of weakness and poor coordination. Speech and feeding specialists may recommend thickened feeds, tube feeding, or gastrostomy to improve nutrition and lower the risk of aspiration.
Gentle stretching, positioning, and range-of-motion therapy may help limit contractures and improve comfort. Splints, braces, and careful seating can support joints and make daily care easier.
Retinal bleeding and brain injury can lead to major vision problems in fetal akinesia-cerebral and retinal hemorrhage syndrome. Low-vision support, visual stimulation suited to the child’s abilities, and regular eye follow-up may help families make the most of remaining vision.
Your genes may have an impact on how drugs work for you
For fetal akinesia-cerebral and retinal hemorrhage syndrome, there are no well-established genetic findings that doctors use to predict how medicines will work, mainly because treatment is usually focused on supportive care rather than a standard set of drugs. Many living with this condition may still need medicines for related problems, such as seizures, pain, or muscle stiffness, and response can vary from one person to another based on overall health, age, and how serious the brain and eye bleeding has been. In day-to-day care, this means doctors usually choose and adjust medicines carefully by watching how the person responds, rather than using a gene-based medication plan.
Pharmacological treatments
For fetal akinesia-cerebral and retinal hemorrhage syndrome, there is no standard medicine that treats the underlying genetic cause. Care is usually supportive and depends on the problems a baby has at birth or soon after, such as seizures, discomfort, feeding trouble, or breathing problems. Drug treatments are not about fixing everything at once, but about easing symptoms and supporting vital functions. Because this condition is rare and often severe, treatment for fetal akinesia-cerebral and retinal hemorrhage syndrome is usually planned case by case in a neonatal or intensive care setting.
There is no disease-specific medication proven to reverse fetal akinesia-cerebral and retinal hemorrhage syndrome. Medicines are chosen to manage complications rather than to cure the condition itself.
If seizures occur, doctors may use anti-seizure drugs such as phenobarbital, levetiracetam, or phenytoin. The choice depends on the baby’s age, overall stability, and how well the seizures come under control.
Some babies need medicines for comfort, especially during intensive care or procedures. Options may include acetaminophen or stronger medicines such as morphine or fentanyl when close monitoring is available.
When breathing support or other invasive care is needed, sedative medicines such as midazolam may be used. These drugs do not treat the syndrome itself, but they can help reduce distress and make urgent care safer.
Genetic influences
Fetal akinesia-cerebral and retinal hemorrhage syndrome is considered a genetic condition and is most often linked to harmful changes in both copies of the JAM3 gene. This usually follows an autosomal recessive inheritance pattern, which means each parent typically carries one changed copy but does not have the syndrome themselves. A change in a gene (mutation or variant) can sometimes affect health. In this condition, JAM3 changes interfere with normal blood vessel and tissue development, which helps explain the severe problems with fetal movement and the bleeding in the brain and eyes. If a pregnancy has been affected, the chance can recur in future pregnancies, so genetic counseling and carrier testing may help families understand their risks and options.
Is Fetal akinesia-cerebral and retinal hemorrhage syndrome genetic?
Genetics are central to fetal akinesia-cerebral and retinal hemorrhage syndrome. It is linked to harmful gene changes, often inherited from both parents, so genetic testing can help confirm the diagnosis and clarify recurrence risk for future pregnancies.
Having a genetic risk is not necessarily a diagnosis
Gene changes, known as genetic variants, are a normal part of human biology and are common in the general population. Most of these variants do not directly affect health and simply reflect natural differences among people. For many genes, carrying a variant connected with a condition suggests a possible association rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some situations, though, one well-understood variant in a particular gene can be enough on its own to confirm a diagnosis.
Pharmacogenetics—how genetics influence drug effects
For families dealing with fetal akinesia-cerebral and retinal hemorrhage syndrome, treatment is usually centered on supportive care, because there is no proven medicine that corrects the underlying genetic change. In practice, the genetic result is most helpful for confirming the diagnosis, guiding care planning, and helping doctors watch for problems that can come with this condition, rather than for picking one specific drug over another. Not every difference in response is genetic, but with fetal akinesia-cerebral and retinal hemorrhage syndrome, doctors usually choose medicines based on the baby’s symptoms, overall stability, and which organs are affected. If seizures, breathing problems, or feeding difficulties occur, those treatments are tailored to the situation, and doses may need careful adjustment because very sick newborns can handle medicines differently. Genetic testing for fetal akinesia-cerebral and retinal hemorrhage syndrome can also help families understand recurrence risk in future pregnancies, even though it does not currently provide a personalized drug plan for this rare disorder.
Interactions with other conditions
Fetal akinesia-cerebral and retinal hemorrhage syndrome is usually considered as part of a broader group of very severe conditions that reduce a baby’s movement before birth, so doctors often need to sort it apart from other causes of fetal akinesia, muscle weakness, or joint contractures. Another important aspect is how it may link with other diseases. Because this syndrome can involve bleeding in the brain and eyes, the medical team may also check for problems that can look similar, such as blood-clotting disorders, certain infections during pregnancy, or other rare genetic conditions that affect the nervous system. In day-to-day care, this matters because one finding on a scan or eye exam does not always point to a single diagnosis, and several conditions can overlap in how they appear before birth. For families, the main issue is usually careful testing to understand whether Fetal akinesia-cerebral and retinal hemorrhage syndrome is the only diagnosis present or part of a wider pattern of disease.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Fetal akinesia-cerebral and retinal hemorrhage syndrome?
This rare condition can look similar to other problems that cause very low movement before birth, such as severe muscle or nerve conditions, some genetic conditions that lead to stiff, fixed joints, and serious lack of oxygen or brain injury around the time of birth. Bleeding in the brain and eyes can also happen with bleeding disorders, severe infections, or birth-related injury, so these are often considered too.
History
For families affected by fetal akinesia-cerebral and retinal hemorrhage syndrome, the story often begins before birth, when a baby is noticed to move less than expected during pregnancy. This rare condition came to medical attention through reports of babies with very limited movement before birth, along with serious bleeding in the brain and eyes. Because these findings are uncommon and severe, early doctors recognized that they seemed to form a distinct pattern rather than a random mix of problems.
Initially understood only through symptoms, later research helped show that fetal akinesia-cerebral and retinal hemorrhage syndrome was part of a broader group of disorders linked to reduced fetal movement. Early case reports focused on what doctors could observe on scans, at delivery, or during specialist examinations after birth. As more cases were described, clinicians began to see that the condition could also include joint contractures, muscle weakness, and other effects that happen when a baby moves very little in the womb.
In recent decades, awareness has grown as imaging, newborn care, and genetic testing have improved. That has made it easier to recognize the early symptoms of fetal akinesia-cerebral and retinal hemorrhage syndrome and to separate it from other causes of reduced fetal movement or bleeding around birth. Understandings have changed, but the central picture has stayed similar: this is a very rare syndrome marked by poor movement before birth and major injury involving the brain and retina, the light-sensitive layer at the back of the eye.
Today, the history of fetal akinesia-cerebral and retinal hemorrhage syndrome is still being written, largely through detailed case reports and international collaboration. Many living with rare conditions benefit when doctors compare notes across centers, because each carefully documented case adds to what is known about diagnosis, supportive care, and what families might expect. Even though the condition remains rare, the medical understanding of it is clearer now than it was when it was first described.